AB2 Bio
is a biotechnology company that researches and develops novel therapeutics for the treatment of inflammatory diseases... Read moreAB2 Bio
is a biotechnology company that researches and develops novel therapeutics for the treatment of inflammatory diseases... Read more
News
Feb 28, 2025
Global Legal Chronicle
AB2 Bio: AB2 Bio Ltd's Option and Licensing Agreement With Nippon Shinyaku
Jan 28, 2025
Biospectrum Asia
AB2 Bio: AB2 Bio signs licensing agreement worth $500 M with Nippon Shinyaku for ultra-rare autoimmune disease treatment
Mar 08, 2023
Clinical Trials Arena
AB2 Bio: AB2 Bio concludes subject enrolment in trial of Tadekinig alfa for HLH
Jan 05, 2021
Benzinga
AB2 Bio: AB2 Bio to Participate in Orphan Disease Panel Discussion at the LifeSci Partners 10th Annual Healthcare Corporate Access Event
Oct 29, 2020
Contract Pharma
AB2 Bio: AB2 Bio and WuXi Biologics Enter Collaboration
Mar 03, 2020
startupticker
AB2 Bio: AB2 Bio prepares market entry of its lead product
Mar 21, 2019
BioPortfolio
Ab2 Bio: AB2 Bio Announces Readiness for Recruitment in Pivotal Phase 3 Trial of Tadekinig Alfa a Novel Human Recombinant Interleukin18 Binding Protein in Children with Genetic Diagnosis of NLRC4MAS Mutation or XIAP Deficiency with Amended Design in the U.S.
Apr 03, 2017
The Pharma Letter
Ab2 Bio: AB2 Bio receives positive news from FDA on autoinflammatory candidate
Nov 10, 2016
NewsMaker
Press Release: Ab2 Bio :
Global Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2016
Jan 14, 2016
startupticker
Ab2 Bio: AB2 Bio Ltd raises CHF 21 million in Series B financing round
AB2 Bio Competitors
1
2
3
4
5
6
7